These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 35137003)
1. Correction to: Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling. Luo L; Cai Y; Zhang Y; Hsu CG; Korshunov VA; Long X; Knight PA; Berk BC; Yan C Cardiovasc Res; 2023 May; 119(3):879. PubMed ID: 35137003 [No Abstract] [Full Text] [Related]
2. Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling. Luo L; Cai Y; Zhang Y; Hsu CG; Korshunov VA; Long X; Knight PA; Berk BC; Yan C Cardiovasc Res; 2022 Sep; 118(12):2703-2717. PubMed ID: 34550322 [TBL] [Abstract][Full Text] [Related]
3. Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation. Xu Y; Ge L; Rui Y; Wang Y; Wang Z; Yang J; Shi Y; Dong Z; Zhang Y; Zhang R; Yang T; Lv L; Xiang F; Chen S; Song A; Li T; Liu M; Guo Y Eur J Pharmacol; 2024 Apr; 968():176422. PubMed ID: 38365108 [TBL] [Abstract][Full Text] [Related]
4. Cezanne is a critical regulator of pathological arterial remodelling by targeting β-catenin signalling. An W; Luong LA; Bowden NP; Yang M; Wu W; Zhou X; Liu C; Niu K; Luo J; Zhang C; Sun X; Poston R; Zhang L; Evans PC; Xiao Q Cardiovasc Res; 2022 Jan; 118(2):638-653. PubMed ID: 33599243 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis. Planas-Rigol E; Terrades-Garcia N; Corbera-Bellalta M; Lozano E; Alba MA; Segarra M; Espígol-Frigolé G; Prieto-González S; Hernández-Rodríguez J; Preciado S; Lavilla R; Cid MC Ann Rheum Dis; 2017 Sep; 76(9):1624-1634. PubMed ID: 28606962 [TBL] [Abstract][Full Text] [Related]
6. PVAT targets VSMCs to regulate vascular remodelling: angel or demon. Zhang YY; Shi YN; Zhu N; Zhao TJ; Guo YJ; Liao DF; Dai AG; Qin L J Drug Target; 2021 Jun; 29(5):467-475. PubMed ID: 33269623 [TBL] [Abstract][Full Text] [Related]
7. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cheong A; Li J; Sukumar P; Kumar B; Zeng F; Riches K; Munsch C; Wood IC; Porter KE; Beech DJ Cardiovasc Res; 2011 Feb; 89(2):282-9. PubMed ID: 20884640 [TBL] [Abstract][Full Text] [Related]
8. New aspects of vascular remodelling: the involvement of all vascular cell types. McGrath JC; Deighan C; Briones AM; Shafaroudi MM; McBride M; Adler J; Arribas SM; Vila E; Daly CJ Exp Physiol; 2005 Jul; 90(4):469-75. PubMed ID: 15894533 [TBL] [Abstract][Full Text] [Related]
9. Deletion of large-conductance calcium-activated potassium channels promotes vascular remodelling through the CTRP7-mediated PI3K/Akt signaling pathway. Bi J; Duan Y; Wang M; He C; Li X; Zhang X; Tao Y; Du Y; Liu H Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 54(12):1-11. PubMed ID: 36514218 [TBL] [Abstract][Full Text] [Related]
10. miR-214-3p-Sufu-GLI1 is a novel regulatory axis controlling inflammatory smooth muscle cell differentiation from stem cells and neointimal hyperplasia. He S; Yang F; Yang M; An W; Maguire EM; Chen Q; Xiao R; Wu W; Zhang L; Wang W; Xiao Q Stem Cell Res Ther; 2020 Nov; 11(1):465. PubMed ID: 33143723 [TBL] [Abstract][Full Text] [Related]
11. Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response. Ogawa H; Ohashi K; Ito M; Shibata R; Kanemura N; Yuasa D; Kambara T; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Otaka N; Kawanishi H; Yamaguchi S; Enomoto T; Abe T; Kaneko M; Takefuji M; Murohara T; Ouchi N Cardiovasc Res; 2020 Jan; 116(1):237-249. PubMed ID: 30874788 [TBL] [Abstract][Full Text] [Related]
12. Neutrophils induce smooth muscle hyperplasia via neutrophil elastase-induced FGF-2 in a mouse model of asthma with mixed inflammation. Ogawa H; Azuma M; Tsunematsu T; Morimoto Y; Kondo M; Tezuka T; Nishioka Y; Tsuneyama K Clin Exp Allergy; 2018 Dec; 48(12):1715-1725. PubMed ID: 30171733 [TBL] [Abstract][Full Text] [Related]
13. Role of hsa_circ_0000280 in regulating vascular smooth muscle cell function and attenuating neointimal hyperplasia via ELAVL1. Wang Z; Wang H; Guo C; Yu F; Zhang Y; Qiao L; Zhang H; Zhang C Cell Mol Life Sci; 2022 Dec; 80(1):3. PubMed ID: 36477660 [TBL] [Abstract][Full Text] [Related]
15. ORAI1 Ca Shawer H; Norman K; Cheng CW; Foster R; Beech DJ; Bailey MA Front Cell Dev Biol; 2021; 9():653812. PubMed ID: 33937254 [TBL] [Abstract][Full Text] [Related]
16. C1q/TNF-related protein 4 mediates proliferation and migration of vascular smooth muscle cells during vascular remodelling. Liu J; Long X; Li H; Yan Q; Wang L; Qin Z; Zhang H Clin Transl Med; 2023 May; 13(5):e1261. PubMed ID: 37221646 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Tang Z; Wang A; Yuan F; Yan Z; Liu B; Chu JS; Helms JA; Li S Nat Commun; 2012 Jun; 3():875. PubMed ID: 22673902 [TBL] [Abstract][Full Text] [Related]